Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: Arch Virol. 2011 Dec 22;157(3):455–465. doi: 10.1007/s00705-011-1180-z

Table 1.

Frequency of protease and reverse transcriptase resistance-related mutations from South African HIV-1 subtype C isolates

Resistance-associated
mutationsa
Frequency
(%)
Coding nucleotideb
Wild type Mutant
Protease (n = 29)
 L10V 2 (7%) CTT GTT
 M36I 26 (90%) ATG ATA/ATC
 M36L 3 (10%) ATG CTG
 L60E 4 (4%) CTG/CTA/
 CTC
GAA
 L63S 3 (10%) AGC
 L63P 8 (27.5%) CCC/CCT
 L63F 1 (3%) TTC
 L63T 1 (3%) ACT
 L63V 3 (10%) GTC
 A71T 1 (3%) GCT ACT
 T74S 2 (6%) ACC TCC
 V77I 2 (6%) GTT ATT
 V82I 1 (3%) GTT ATT
 I93L 27 (94%) ATT GTT/CTC
Reverse transcriptase (n = 43)
 V90I 2 (4.6%) GTT ATT
 A98S 6 (13.9%) GCC TCC
 V90I/K103N 1 (2.3%)
 K103N 2 (4.6%) AAA AAC
 V118I 2 (4.6%) GCT ATC
 E138A 4 (9.3%) GAA/GAG GCA/
 GCG
 V118I/E138A 1 (2.3%)
 V118I/E138A/
 V179D
1 (2.3%)
 V179I 3 (6.9%) GTT ATC
a

Resistance mutations were identified according to the Stanford Genotype Resistance Interpretation Algorithm

b

Nonsynonymous codons introducing substitutions at positions related to drug resistance. The wild-type reference is the HIV-1 subtype B consensus sequence